These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 31062898)

  • 1. Treatment and outcomes in classic Hodgkin lymphoma post-transplant lymphoproliferative disorder in children.
    Twist CJ; Hiniker SM; Gratzinger D; Gutkin PM; Merriott DJ; Iagaru A; Link MP; Donaldson SS
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27803. PubMed ID: 31062898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma-like posttransplant lymphoproliferative disorder (HL-like PTLD) simulates monomorphic B-cell PTLD both clinically and pathologically.
    Pitman SD; Huang Q; Zuppan CW; Rowsell EH; Cao JD; Berdeja JG; Weiss LM; Wang J
    Am J Surg Pathol; 2006 Apr; 30(4):470-6. PubMed ID: 16625093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classical Hodgkin lymphoma-type PTLD after solid organ transplantation in children: a report on 17 patients treated according to subsequent GPOH-HD treatment schedules.
    Kampers J; Orjuela-Grimm M; Schober T; Schulz TF; Stiefel M; Klein C; Körholz D; Mauz-Körholz C; Kreipe H; Beier R; Maecker-Kolhoff B
    Leuk Lymphoma; 2017 Mar; 58(3):633-638. PubMed ID: 27685149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hodgkin-like posttransplant lymphoproliferative disorder in children: does it differ from posttransplant Hodgkin lymphoma?
    Ranganathan S; Webber S; Ahuja S; Jaffe R
    Pediatr Dev Pathol; 2004; 7(4):348-60. PubMed ID: 14564542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T-lymphocyte therapy for post-transplant lymphoproliferative disorder after solid organ transplantation in children.
    Chiou FK; Beath SV; Wilkie GM; Vickers MA; Morland B; Gupte GL
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29388302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathologic and clinical features of Hodgkin lymphoma--like posttransplant lymphoproliferative disease.
    Krishnamurthy S; Hassan A; Frater JL; Paessler ME; Kreisel FH
    Int J Surg Pathol; 2010 Aug; 18(4):278-85. PubMed ID: 19578050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-transplant lymphoproliferative disorder after solid-organ transplant in children.
    Absalon MJ; Khoury RA; Phillips CL
    Semin Pediatr Surg; 2017 Aug; 26(4):257-266. PubMed ID: 28964482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Central Nervous System Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder.
    Hori YS; Nagakita K; Ebisudani Y; Aoi M; Fukuhara T; Shinno Y
    World Neurosurg; 2018 Jun; 114():230-234. PubMed ID: 29609086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of post-transplant lymphoproliferative disease presenting as CD20-expressing, Epstein-Barr-virus positive Hodgkin lymphoma.
    Stern M; Herrmann R; Rochlitz C; Dirnhofer S; Pless M
    Eur J Haematol; 2005 Mar; 74(3):267-70. PubMed ID: 15693799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of kidney retransplantation in recipients with prior post-transplant lymphoproliferative disorder.
    Rouphael B; Lankireddy S; Lazaryan A; Kukla A; Ibrahim HN; Matas AJ; Issa N
    Clin Transplant; 2016 Jan; 30(1):60-5. PubMed ID: 26497471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hodgkin lymphoma post-transplant lymphoproliferative disorder: A comparative analysis of clinical characteristics, prognosis, and survival.
    Rosenberg AS; Klein AK; Ruthazer R; Evens AM
    Am J Hematol; 2016 Jun; 91(6):560-5. PubMed ID: 26928381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hodgkin lymphoma-like posttransplantation lymphoproliferative disorder.
    Semakula B; Rittenbach JV; Wang J
    Arch Pathol Lab Med; 2006 Apr; 130(4):558-60. PubMed ID: 16594752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
    Guerra-García P; Bomken S; Ling R; Lazareva A; Gupte G; Amrolia P; Andrés M; Diez-Sebastián J; Taj MM
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31053. PubMed ID: 38757407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stage IV Classical Hodgkin Lymphoma-type Posttransplant Lymphoproliferative Disorder in a Pediatric Liver Transplant Patient: A Case Report and Review of the Literature.
    Choi S; Hong KT; Choi JY; Ahn HY; Ko JS; Suh KS; Park SH; Cheon JE; Shin HY; Kang HJ
    J Pediatr Hematol Oncol; 2021 Oct; 43(7):e1015-e1019. PubMed ID: 33769384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.
    Ghobrial IM; Habermann TM; Maurer MJ; Geyer SM; Ristow KM; Larson TS; Walker RC; Ansell SM; Macon WR; Gores GG; Stegall MD; McGregor CG
    J Clin Oncol; 2005 Oct; 23(30):7574-82. PubMed ID: 16186599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorders localizing in the adenotonsillar region: report from the PTLD.Int survey.
    Khedmat H; Taheri S
    Ann Transplant; 2011; 16(1):109-16. PubMed ID: 21436784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein-Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient.
    Basso S; Zecca M; Calafiore L; Rubert L; Fiocchi R; Paulli M; Quartuccio G; Guido I; Sebastiani R; Croci GA; Beschi C; Nardiello I; Ginevri F; Cugno C; Comoli P
    Pediatr Transplant; 2013 Nov; 17(7):E168-73. PubMed ID: 23992468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disorder in liver recipients: Characteristics, management, and outcome from a single-centre experience with >1000 liver transplantations.
    Mumtaz K; Faisal N; Marquez M; Healey A; Lilly LB; Renner EL
    Can J Gastroenterol Hepatol; 2015; 29(8):417-22. PubMed ID: 26076399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brentuximab vedotin plus sirolimus in the treatment of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder: a case-based review.
    Zhou K; Gong D; Han Y; Huang W
    Ann Hematol; 2024 Jul; 103(7):2207-2213. PubMed ID: 37749317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CNI withdrawal for post-transplant lymphoproliferative disorders in kidney transplant is an independent risk factor for graft failure and mortality.
    Rabot N; Büchler M; Foucher Y; Moreau A; Debiais C; Machet MC; Kessler M; Morelon E; Thierry A; Legendre C; Rivalan J; Kamar N; Dantal J
    Transpl Int; 2014 Sep; 27(9):956-65. PubMed ID: 24964147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.